GSK plc Announces Share Buyback Transaction

GSK plc has announced the purchase of 253,331 of its ordinary shares at a volume-weighted average price of 1,482.92p per share on 15 September 2025. The shares were purchased as part of the company's existing buyback program, which was initiated on 4 June 2025. Following this transaction, GSK plc will hold 247,028,723 ordinary shares in treasury and have 4,068,374,245 ordinary shares in issue, excluding treasury shares. The total number of voting rights in the company remains at 4,068,374,245. The purchased shares will be held as treasury shares, and the percentage of voting rights attributable to these shares is 6.07%. The transaction was executed through Merrill Lynch International on the London Stock Exchange.